VRDN Overview
Upcoming Projects (VRDN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (VRDN)
-
Discussing the Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease
Ticker: VRDN
Executed On: Sep 17, 2024 at 11:30 AM EDT -
Discussing Thyroid Eye Disease (TED), the outlook for VRDN-001 and VRDN-003, and the THRIVE trial from Viridian
Ticker: VRDN
Executed On: Aug 19, 2024 at 05:30 PM EDT -
A Second Take: Discussing targets in TED (IGF-1R, IL-6 & FcRn class), including their available clinical data.
Tickers: HZNP, VRDN, IMVT, ARGX
Executed On: Sep 19, 2023 at 09:45 AM EDT -
Discussing targets in TED (IGF-1R, IL-6 & FcRn class), including their available clinical data.
Tickers: HZNP, VRDN, IMVT, ARGX
Executed On: Sep 18, 2023 at 07:30 PM EDT -
Exploring the TED treatment landscape with an ophthalmologist focusing on Horizon's Tepezza (teprotumumab-trbw), Immunovant's Batoclimab (IMVT-1401), and Viridian's VRDN-001.
Tickers: HZNP, VRDN, IMVT
Executed On: May 23, 2023 at 05:30 PM EDT -
A Third Opinion: Discussing Tepezza's launch and remaining unmet medical need in treating Thyroid Eye Disease (TED)
Tickers: HZNP, VRDN, ValenzaBio, VasaraGen
Executed On: Feb 01, 2022 at 12:40 PM EST -
A Second Opinion: Discussing Tepezza's launch and remaining unmet medical need in treating Thyroid Eye Disease (TED)
Tickers: HZNP, VRDN, ValenzaBio, VasaraGen
Executed On: Jan 27, 2022 at 07:00 PM EST -
Discussing Tepezza's launch and remaining unmet medical need in treating Thyroid Eye Disease (TED)
Tickers: HZNP, VRDN, ValenzaBio, VasaraGen
Executed On: Jan 26, 2022 at 02:00 PM EST
Expired Projects (VRDN)
-
Evaluating Verdant Biopharm's VRDN-001 for Chronic Thyroid Eye Disease (TED) Treatment, with an Upcoming Phase 2 Data Release
Ticker: VRDN
Execute By: Aug 31, 2023
Upcoming & Overdue Catalysts (VRDN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (VRDN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
